By the end of the year, THC products will be available for purchase in some Georgia pharmacies, CNN reported Oct. 20. 

Biotech companies and drugmakers are shelving their AI-designed therapeutics after a series of clinical setbacks, Endpoints News reported Oct. 19. 

For the first time, an experimental antiviral for dengue virus showed efficacy in humans, Johnson & Johnson said Oct. 20. 

Eli Lilly and Novo Nordisk are working to get weight-loss drugs approved for children as young as 6, Bloomberg reported Oct. 20.

CVS is voluntarily pulling from its shelves some common decongestants that contain an active ingredient FDA advisors have deemed ineffective at relieving congestion. 

Pharmacy leaders have already cracked the code of hospital C-suites, but increasingly, they're entering executive positions across health systems. 

A California health system has noted an "exponential" increase in patients using Wegovy, Mounjaro and other similar drugs for weight loss, according to a first-of-its-kind study.

Reata Pharmaceuticals — a rare disease drugmaker recently acquired by Biogen — filed a WARN notice Oct. 9, alerting Texas officials of its plans to cut 113 positions. The layoffs will take effect Nov. 27. 

Independent pharmacies and lawmakers are asking the federal government to probe UnitedHealth Group's proposed scoop of Amedisys, one of the largest home health and hospice care providers in the U.S.

Hospital groups and healthcare think tanks are urging CMS to revise its proposal to address medication shortages, which have been persistent for decades and have struck multiple therapeutic areas in 2023.